Why the MGC Pharma (ASX:MXC) share price is smoking the market today

The MGC Pharmaceuticals Ltd (ASX:MXC) share price is smoking the market on Wednesday after releasing an update on its UK operations…

| More on:

Should you invest $1,000 in Future Generation Investment Company right now?

Before you buy Future Generation Investment Company shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Future Generation Investment Company wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 3 April 2025

cannabis leaves on a rising line graph representing growth of ASX cannabis share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has been smoking the market on Wednesday.

In afternoon trade the medicinal cannabis company's shares are up 8% to 3.9 cents.

This latest gain means the MGC Pharma share price is now up almost 63% since the start of 2021.

Why is the MGC Pharma share price smoking the market today?

Investors have been buying MGC Pharma's shares today following an update on its listing in the United Kingdom.

According to the release, the company's shares were admitted to the standard sector of the London Stock Exchange (LSE) on Tuesday.

This admission follows the completion of a successful capital raise of 6.5 million pounds through an oversubscribed placement to UK based institutional funds, high net worth family offices, and professional investors.

This made MGC Pharma the first cannabis-sector company to IPO on the main market of the LSE in the United Kingdom.

Management advised that the net proceeds of the capital raise will be used to meet the costs associated with its priority clinical trials including ArtemiC and CannEpil. It will also be used to increase the distribution of its product range, general working capital, and the completion of its manufacturing facilities in Malta.

"Significant moment"

MGC Pharma's Chief Executive and Managing Director, Roby Zomer, believes this is a significant moment for the company.

He said: "The LSE listing is a hugely significant moment for MGC Pharma, our admission to LSE follows the successful capital raising of £6.5 million which will be used to immediately commence the priority clinical research trials of our leading products, expand our distribution network into key sales markets, as well as advance the construction of our manufacturing facilities in Malta."

"We are proud to make history as the first medical cannabis company on this historic Exchange. I would like to thank the MGC Pharma team and the advisors for all their hard work to make this happen. We look forward to updating our new and existing shareholders as we progress this programme," he added.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Rising share price chart.
Share Gainers

Why DroneShield, Lynas, Novonix, and Orthocell shares are storming higher today

These shares are starting the week with a bang. Let's find out why.

Read more »

Happy young woman saving money in a piggy bank.
Share Gainers

3 ASX shares that would already have more than doubled your money in 2025

An investment in any of these ASX shares on 2 January would have more than doubled your money by now.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great end to the week's trading today...

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Liontown, Newmont, Paladin Energy, and ResMed shares are charging higher today

These shares are ending the week on a positive note.

Read more »

Man on computer looking at graphs
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were back to the races this hump day...

Read more »

Rising share price chart.
Share Gainers

Why Orthocell, Paladin Energy, Telix, and Woodside shares are racing higher today

These shares are having a stronger day than most. But why?

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Why is this ASX 200 uranium stock rocketing 17% on Wednesday?

The ASX 200 uranium stock is racing higher today. But why?

Read more »

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wild return for ASX shares this Tuesday.

Read more »